In addition, the observation that L1CAM promotes the enrichment of immunosuppressive T cells within the tumour, contributing to immune evasion and suppression,31, 32 supports the rationale of the combination between L1CAM blockade and immunotherapy as a strategy to overcome tumour immune escape. This evidence concerns the gene L1CAM and neoplasm.